FULL INTEGRATED SCREEN PART I (MATERNAL SERUM)

Sample Reports
Sample Abnormal Report
Sample Normal Report

Test Documentation
Prenatal Screen Information Sheet

Components
Includes: Pregnancy Associated Plasma Protein-A (PAPP-A) and Nuchal Translucency (NT).
Risk assessment not reported until Full Integrated Screen Part II (Maternal Serum) is completed.

Specimen Required
Draw blood in a plain red-top tube. Centrifuge, separate serum from cells within 2 hours of collection and send 1.0 mL serum (0.6 mL minimum) refrigerated in a screw-capped plastic vial. Sample should be collected between 10 weeks 0 days (CRL 32 mm) and 13 weeks 6 days gestation (CRL 79.9 mm). Completed Prenatal Screen Information Sheet located (above) under Test Documentation and in the Appendices of the Test Directory, must accompany sample.

Alternate Specimen
Serum: SST

Rejection Criteria
Moderately hemolyzed specimens

Methodology
Chemiluminescent Immunoenzymatic Assay

Stability
Room Temperature: 5 days; Refrigerated: 7 days; Frozen: 2 months

Reference Range
By report

Performed
Monday-Friday

Turnaround Time4 days
Test CodeFI1NT
CPT-4 Code (s)
84163
LOINC Codes
Interpretation:   75365-7  

Warde
Medical
Laboratory